Cardiome Pharma Corporation Free Cash Flow:
-5.421M for Dec. 31, 2012Cardiome Pharma Corporation Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -5.421M |
| Sept. 30, 2012 | -7.095M |
| June 30, 2012 | -4.829M |
| March 31, 2012 | -8.186M |
| Dec. 31, 2011 | -5.983M |
| Sept. 30, 2011 | -6.56M |
| June 30, 2011 | -8.511M |
| March 31, 2011 | -7.574M |
| Dec. 31, 2010 | 23.25M |
| Sept. 30, 2010 | -5.16M |
| June 30, 2010 | -6.995M |
| March 31, 2010 | -9.001M |
| Dec. 31, 2009 | -5.527M |
| Sept. 30, 2009 | 6.455M |
| June 30, 2009 | 47.11M |
| March 31, 2009 | -10.29M |
| Dec. 31, 2008 | -3.486M |
| Sept. 30, 2008 | -11.94M |
| June 30, 2008 | -19.23M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Aug. 31, 2003 | Go Pro |
| May 31, 2003 | Go Pro |
| Feb. 28, 2003 | Go Pro |
| Nov. 30, 2002 | Go Pro |
| Aug. 31, 2002 | Go Pro |
| May 31, 2002 | Go Pro |
| Feb. 28, 2002 | Go Pro |
| Nov. 30, 2001 | Go Pro |
| Aug. 31, 2001 | Go Pro |
| May 31, 2001 | Go Pro |
| Feb. 28, 2001 | Go Pro |
| Nov. 30, 2000 | Go Pro |
| Aug. 31, 2000 | Go Pro |
| May 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
CRME Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Merrimack Pharmaceuticals | -21.20M |
| Chemocentryx | -7.85M |
| QLT |
CRME Free Cash Flow Rankings
| Overall |
57th percentile 3365 of 8002 |
| Sector |
41st percentile 397 of 684 in Healthcare |
| Industry |
60th percentile 98 of 248 in Biotechnology |
CRME Free Cash Flow Range, Past 5 Years
| Minimum | -19.23M | Jun 2008 |
| Maximum | 47.11M | Jun 2009 |
| Average | -2.578M |
CRME News
Cardiome Pharma Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 13
Seeking Alpha May 13
